DK0822808T3 - Kompositmateriale med natriumstivelsesglycolat som bærermateriale og produkter deraf - Google Patents

Kompositmateriale med natriumstivelsesglycolat som bærermateriale og produkter deraf

Info

Publication number
DK0822808T3
DK0822808T3 DK96913671T DK96913671T DK0822808T3 DK 0822808 T3 DK0822808 T3 DK 0822808T3 DK 96913671 T DK96913671 T DK 96913671T DK 96913671 T DK96913671 T DK 96913671T DK 0822808 T3 DK0822808 T3 DK 0822808T3
Authority
DK
Denmark
Prior art keywords
sodium starch
starch glycolate
active substances
products
composite material
Prior art date
Application number
DK96913671T
Other languages
English (en)
Inventor
Fabio Carli
Jatin J Shah
Edward C Shinal
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Application granted granted Critical
Publication of DK0822808T3 publication Critical patent/DK0822808T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96913671T 1995-04-20 1996-04-17 Kompositmateriale med natriumstivelsesglycolat som bærermateriale og produkter deraf DK0822808T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42543495A 1995-04-20 1995-04-20
PCT/IB1996/000492 WO1996032931A2 (en) 1995-04-20 1996-04-17 Composite with sodium starch glycolate as a support material and products thereof

Publications (1)

Publication Number Publication Date
DK0822808T3 true DK0822808T3 (da) 2000-10-09

Family

ID=23686568

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96913671T DK0822808T3 (da) 1995-04-20 1996-04-17 Kompositmateriale med natriumstivelsesglycolat som bærermateriale og produkter deraf

Country Status (11)

Country Link
EP (1) EP0822808B1 (da)
JP (1) JPH11503749A (da)
AT (1) ATE194909T1 (da)
AU (1) AU5658496A (da)
CA (1) CA2218486A1 (da)
DE (1) DE69609501T2 (da)
DK (1) DK0822808T3 (da)
ES (1) ES2149471T3 (da)
GR (1) GR3034617T3 (da)
PT (1) PT822808E (da)
WO (1) WO1996032931A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1295289B1 (it) * 1997-10-07 1999-05-04 Telos S R L Co-macinati per uso cosmetico e dermatologico
DE60205491T2 (de) * 2001-06-29 2006-06-01 Eurand Pharmaceuticals Ltd. Verfahren zur arzneimittelaktivierung mittels schwingmühle
NZ530827A (en) 2001-06-29 2005-06-24 Eurand Pharmaceuticals Ltd Process for activation of drugs in a vibrational mill
PT1558582E (pt) 2003-07-22 2006-05-31 Arena Pharm Inc Derivados de diaril- e aril-heteroaril-ureia como moduladores do receptor de serotonina 5-ht2a uteis para a profilaxia e tratamento de desordens relacionadas com o mesmo
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
ES2421237T7 (es) 2007-08-15 2013-09-30 Arena Pharmaceuticals, Inc. Derivados de imidazo[1,2-a]piridin como moduladores del receptor serotoninérgico 5ht2a en el tratamiento de trastornos relacionados con el mismo
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
PT2364142T (pt) 2008-10-28 2018-04-23 Arena Pharm Inc Composições de um modulador do recetor da serotonina 5-ht2a para o tratamento de distúrbios com ele relacionados
ITMI20120092A1 (it) 2012-01-26 2013-07-27 Micro Macinazione S A Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
RU2017145976A (ru) 2015-06-12 2019-07-15 Аксовант Сайенсиз Гмбх Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна
KR20180064373A (ko) 2015-07-15 2018-06-14 엑소반트 사이언시즈 게엠베하 신경퇴행성 질환과 관련된 환각의 예방 및 치료에 유용한 5-ht2a 세로토닌 수용체의 조절자로서의 다이아릴 및 아릴헤테로아릴 우레아 유도체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5132719A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Iyakuhinnoshorihoho
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
US5130140A (en) * 1989-09-14 1992-07-14 Hoeschst-Roussel Pharmaceuticals Inc. Method of making direct dry compressible acetaminophen composition

Also Published As

Publication number Publication date
CA2218486A1 (en) 1996-10-24
DE69609501T2 (de) 2001-03-29
DE69609501D1 (de) 2000-08-31
EP0822808B1 (en) 2000-07-26
GR3034617T3 (en) 2001-01-31
ES2149471T3 (es) 2000-11-01
ATE194909T1 (de) 2000-08-15
JPH11503749A (ja) 1999-03-30
AU5658496A (en) 1996-11-07
EP0822808A2 (en) 1998-02-11
WO1996032931A2 (en) 1996-10-24
WO1996032931A3 (en) 1996-11-28
PT822808E (pt) 2000-12-29

Similar Documents

Publication Publication Date Title
YU10699A (sh) Upotreba glp-1, glp-1 analoga i glp-1 derivata za proizvodnju leka
DK0822808T3 (da) Kompositmateriale med natriumstivelsesglycolat som bærermateriale og produkter deraf
MY124695A (en) Novel composition and use.
CO4940403A1 (es) Formulaciones de liberacion prolongada de derivados de eri- tromicina
GEP20053473B (en) High Potency Dihydroergotamine Compositions
AU8183198A (en) Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations
NO20002785L (no) Adamantanderivater
NO20002786L (no) Adamantanderivater
MY118371A (en) Tetrahydrolipstatin containing compositions
AR017780A1 (es) Conjugado del factor de liberacion de hormona de crecimiento-polietilenenglicol (hgrf-peg) y metodo para la preparacion en sitio-especifico del mismo.
CO5280073A1 (es) Composiciones
BG103714A (en) Pararacetamol-containing tablet
CL2009001899A1 (es) Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01).
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
AP1901A (en) Pharmaceutical composition for modified release insulin sensitiser.
AU8025998A (en) Biologically active materials
NZ515999A (en) Biologically active materials
AR012996A1 (es) Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador.
AU5685300A (en) Solid preparations containing paroxetine
TR200102930T2 (tr) Ruhsal bozuklukların tedavisinde yararlı olan ilaçların üretiminde osanetat kullanımı
HUP9900308A2 (hu) Effervescens gyógyászati készítmények előállítása hengeres tömőrítéssel
ECSP993215A (es) Nueva composicion y uso
ECSP993216A (es) Nueva composicion y uso ii
TW332816B (en) Peptide and carbohydrate
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.